Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Effects of Kratom in People With Past Opioid Use
NCT07218549Phase 1Recruiting
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketum (6 arms). Primary endpoint: Drug Liking Visual Analog Scale at 8 weeks. Started Sep 2026; status: recruiting.
02
Drugs
ketum
Beyond the preview
Go deeper on NCT07218549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07218549.